The ALK rearrangement in FISH-positive/IHC-negative patient with ALK-rearranged Sq-LC (case 2) responded to standard chemotherapy for Sq-LC, which was replaced by ALK inhibitors due to adverse effects. The gene discussed is ALK; the disease is laryngotracheoesophageal cleft.